BIOTRONIK has received CE mark for its Selectra left ventricular lead delivery system for CRT devices. It is a telescopic system with inner catheters that allow the operator to easily navigate branching vessels.
It has an integrated hemostatic valve and sideport and a hydrophilic inner coating. The short soft tip minimizes the risk for dissections and tip prolapse during lead manipulation. The Selectra received U.S. FDA approval last April.
From the latest announcement:
It is a telescopic delivery system for direct delivery of low-profile left ventricular leads that incorporates a slittable hemostatic valve that reduces the complexity involved during a lead implant as well as the likelihood of moving the left ventricular lead as the sheath is removed.
The device’s unique handle design has an integrated side port, allowing for maximum flexibility and one-handed manipulation, which results in ultimate convenience during even the most challenging implantations. The superior shaft design, with its balanced stiffness segmentations, provides optimal torque transmission while preventing kinking of the catheter. The short soft tip design minimizes the risk for dissections during cannulation of the coronary sinus and prolapse during lead maneuvering.
Selectra also incorporates a streamlined, fully integrated hub to minimize handling complexity and maximize the working length of the sheath during implant. Its hydrophilic inner coating reduces friction, thereby increasing the free movement of coronary sinus leads or the subselector catheters during introduction and providing lead dislodgment prevention during the removal of the catheter system.
Press release: BIOTRONIK Announces European Market Approval of Selectra: Advanced New Telescopic CRT Lead Delivery System…
Product page: BIOTRONIK Selectra…
Flashback: Biotronik Launches Selectra Left Ventricular Lead Delivery System in US
